Skip to main content

Advertisement

ADVERTISEMENT

News

Treatment of DFUs w/ Autologous PRP Gel 

https://www.magonlinelibrary.com/doi/abs/10.12968/jowc.2023.0088

A study that evaluated the efficacy and safety of PRP gel prepared using TKKT01 (a processing device candidate by Rohto Pharmaceutical of Japan) in patients with hard-to-heal DFUs met the primary endpoint with 38/47 (80.9%) patients achieving ≥ 50% wound radius reduction. JOWC

Advertisement

Advertisement

Advertisement